MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 136 filers reported holding MERSANA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.11 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,395,000 | +42.9% | 90,000 | 0.0% | 0.02% | +18.8% |
| Q3 2020 | $1,676,000 | -20.4% | 90,000 | 0.0% | 0.02% | -27.3% |
| Q2 2020 | $2,106,000 | +222.5% | 90,000 | -78.2% | 0.02% | +214.3% |
| Q3 2019 | $653,000 | -93.5% | 413,525 | -83.2% | 0.01% | -92.7% |
| Q2 2019 | $9,981,000 | -41.0% | 2,464,415 | -23.4% | 0.10% | -39.6% |
| Q1 2019 | $16,916,000 | +104.5% | 3,216,002 | +58.6% | 0.16% | +82.8% |
| Q4 2018 | $8,272,000 | -55.1% | 2,027,505 | +10.2% | 0.09% | -43.5% |
| Q3 2018 | $18,403,000 | -17.6% | 1,840,333 | +47.1% | 0.15% | -24.9% |
| Q2 2018 | $22,342,000 | +51.9% | 1,250,977 | +34.2% | 0.20% | +39.5% |
| Q1 2018 | $14,704,000 | -0.5% | 932,396 | +3.6% | 0.15% | -2.0% |
| Q4 2017 | $14,783,000 | +79.0% | 899,773 | +88.4% | 0.15% | +59.6% |
| Q3 2017 | $8,260,000 | +68.9% | 477,711 | +36.5% | 0.09% | +54.1% |
| Q2 2017 | $4,890,000 | – | 350,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |